Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
AstraZeneca
Federal Trade Commission
Express Scripts
Healthtrust
Deloitte
Moodys
Accenture
Chubb

Generated: February 25, 2018

DrugPatentWatch Database Preview

PREGNYL Drug Profile

« Back to Dashboard

When do Pregnyl patents expire, and when can generic versions of Pregnyl launch?

Pregnyl is a drug marketed by Organon Usa Inc and is included in one NDA.

The generic ingredient in PREGNYL is gonadotropin, chorionic. Four suppliers are listed for this compound. Additional details are available on the gonadotropin, chorionic profile page.

US Patents and Regulatory Information for PREGNYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc PREGNYL gonadotropin, chorionic INJECTABLE;INJECTION 017692-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Merck
US Department of Justice
Accenture
Moodys
UBS
Express Scripts
Fish and Richardson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot